🔎 Trials Near Me

Home › Autoimmune Diseases › Iowa

Autoimmune Diseases clinical trials in Iowa

7 studies for Autoimmune Diseases are looking for participants at sites in Iowa.

Cities in Iowa

A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

  • The University of Iowa, Iowa City
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT06722235

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

  • University of Iowa, Iowa City
RecruitingPhase 1
Ages 18 to 74 · All sexes · Updated Sep 10, 2026 · NCT07085104

A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

  • The University of Iowa, Iowa City
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT06948318

Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.

  • University of Iowa Hospitals and Clinics, Iowa City
RecruitingPhase 3
Ages 18 to 100 · All sexes · Updated Aug 17, 2026 · NCT06858319

A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections

  • University of Iowa, Iowa City
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Aug 6, 2026 · NCT06056297

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

  • University of Iowa, Iowa City
RecruitingObservational study
All ages · All sexes · Updated Jul 6, 2026 · NCT01351545

A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)

  • University of Iowa, Iowa City
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated May 29, 2026 · NCT04422912

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.